✦ LIBER ✦

The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: Results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials

✍ Scribed by Ira D. Glick; Raymond Mankoski; James M. Eudicone; Ronald N. Marcus; Quynh-Van Tran; Sheila Assunção-Talbott

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ARIPIPRAZOLE IN THE TREATMENT OF SCHIZOA

✍ Reza Moghadam; Ira D. Glick; Raymond Mankoski; James M Eudicone; Quyhn-Van Tran; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Tu1403 Safety and Tolerability Profile o

✍ Chang, Lin; Chey, William D.; Drossman, Douglas A.; Lembo, Anthony; Pimentel, Ma 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A Pooled Analysis of Two Randomized, Dou

✍ Michael E. Geisser; Robert H. Palmer; R. Michael Gendreau; Yong Wang; Daniel J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

EPA-0790 – All-cause discontinuation and

✍ Baker, R.; Fleischhacker, W.W.; Sanchez, R.; Tsai, L.F.; Peters-Strickland, T.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 59 KB

Safety and tolerability of rifaximin for

✍ Schoenfeld, P.; Pimentel, M.; Chang, L.; Lembo, A.; Chey, W. D.; Yu, J.; Paterso 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Poster #S233 ALL-CAUSE DISCONTINUATION A

✍ Eramo, Anna; Fleischhacker, W. Wolfgang; Sanchez, Raymond; Tsai, Lan-Feng; Peter 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 89 KB